Abstract
EGFR, an oncogenic tyrosine kinase receptor, is a relevant target for anti-cancer therapies; survival of cancer cells however, is also maintained by EGFR regardless of its kinase activity. In tumor cells EGFR prevents autophagic cell death by maintaining the intracellular glucose level through interaction and stabilization of the sodium/glucose cotransporter 1 (SGLT1). Since this function of EGFR directly impacts on glucose uptake, positron emission tomography (PET) scans would be a useful biomarker for therapy aimed toward inhibiting the binding of EGFR to SGLT1. Here, we analyzed the possible relationship between the immunoexpression of EGFR in patients with squamous cell lung cancer and the maximum standardized uptake value (SUVmax) of 18F-fluorodeoxyglucose-PET. Membranous immunostaining for EGFR was positive in all patients, and a correlation between EGFR expression and SUVmax was observed (p < 0.05). Therefore, we can conclude that EGFR expression is a common event associated with squamous cell lung carcinomas that positively correlates with SUVmax.
Keywords: EGFR, positron emission tomography, squamous cell lung cancer
Current Radiopharmaceuticals
Title: EGFR Expression Correlates with Maximum Standardized Uptake Value of 18F- fluorodeoxyglucose-PET in Squamous Cell Lung Carcinoma
Volume: 2 Issue: 3
Author(s): Ihab Abdulkader, Alvaro Ruibal, Jose Cameselle-Teijeiro, Francisco Gude, Luis Leon, Patricia Arce-Calisaya, Aida Sanchez-Salmon and Jeronimo Forteza
Affiliation:
Keywords: EGFR, positron emission tomography, squamous cell lung cancer
Abstract: EGFR, an oncogenic tyrosine kinase receptor, is a relevant target for anti-cancer therapies; survival of cancer cells however, is also maintained by EGFR regardless of its kinase activity. In tumor cells EGFR prevents autophagic cell death by maintaining the intracellular glucose level through interaction and stabilization of the sodium/glucose cotransporter 1 (SGLT1). Since this function of EGFR directly impacts on glucose uptake, positron emission tomography (PET) scans would be a useful biomarker for therapy aimed toward inhibiting the binding of EGFR to SGLT1. Here, we analyzed the possible relationship between the immunoexpression of EGFR in patients with squamous cell lung cancer and the maximum standardized uptake value (SUVmax) of 18F-fluorodeoxyglucose-PET. Membranous immunostaining for EGFR was positive in all patients, and a correlation between EGFR expression and SUVmax was observed (p < 0.05). Therefore, we can conclude that EGFR expression is a common event associated with squamous cell lung carcinomas that positively correlates with SUVmax.
Export Options
About this article
Cite this article as:
Abdulkader Ihab, Ruibal Alvaro, Cameselle-Teijeiro Jose, Gude Francisco, Leon Luis, Arce-Calisaya Patricia, Sanchez-Salmon Aida and Forteza Jeronimo, EGFR Expression Correlates with Maximum Standardized Uptake Value of 18F- fluorodeoxyglucose-PET in Squamous Cell Lung Carcinoma, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030175
DOI https://dx.doi.org/10.2174/1874471010902030175 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases
Current Pharmaceutical Design The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Prevalence of HIV in Patients with Malignancy and of Malignancy in HIV Patients in a Tertiary Care Center from North India
Current HIV Research Weka Machine Learning for Predicting the Phospholipidosis Inducing Potential
Current Topics in Medicinal Chemistry Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Structural and Computational Biology of the Molecular Chaperone Hsp90: From Understanding Molecular Mechanisms to Computer-Based Inhibitor Design
Current Topics in Medicinal Chemistry Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression
Current Drug Targets ATRA Entrapped in DSPC Liposome Enhances Anti-metastasis Effect on Lung and Liver During B16F10 Cell Line Metastasis in C57BL6 Mice
Anti-Cancer Agents in Medicinal Chemistry Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Steroidal Cardiac Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitors Exhibit Strong Anti-Cancer Potential <i>in vitro</i> and in Prostate and Lung Cancer Xenografts <i>in vivo</i>
Anti-Cancer Agents in Medicinal Chemistry Innovative Strategies in In Vivo Apoptosis Imaging
Current Medicinal Chemistry The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results
Reviews on Recent Clinical Trials Synthesis and Biological Potential Assessment of 2-Substituted Quinazolin-4(3<i>H</i>)-ones as Inhibitors of Phosphodiesterase-I and Carbonic Anhydrase-II
Medicinal Chemistry Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding
Current Cancer Drug Targets Inhibition of Intercellular Communication between Prostate Cancer Cells by A Specific Anti-STEAP-1 Single Chain Antibody
Anti-Cancer Agents in Medicinal Chemistry Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor
Recent Patents on Anti-Cancer Drug Discovery Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Current Cancer Drug Targets